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The actin cytoskeleton is essential for proper 
functioning of the immune system by regulat-
ing cell movement, cell–cell interactions, cell 
signaling, and cell division. The Wiskott-Aldrich 
syndrome protein (WASP) is uniquely expressed 
in hematopoietic cells and is a key organizer of 
cell shape through coordination of receptor sig-
naling to remodeling of the actin cytoskeleton. 
WASP is critically dependent on its structural 
conformation and is thought to reside in an 
inactive form in the cytoplasm caused by an 
intramolecular interaction between the GTPase 
binding domain and the C-terminal verprolin-
cofilin-acidic domain (Kim et al., 2000). Binding 
of WASP-interacting proteins such as Cdc42 
and Nck can release this autoinhibition, exposing 
the verprolin-cofilin-acidic domain to the Arp2/3 
complex and globular actin, and inducing actin 
polymerization. WASP deficiency affects the 
immune system broadly, and WAS patients suffer 
from immunodeficiency, thrombocytopenia, and 
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X-linked neutropenia (XLN) is caused by activating mutations in the Wiskott-Aldrich  
syndrome protein (WASP) that result in aberrant autoinhibition. Although patients with XLN 
appear to have only defects in myeloid lineages, we hypothesized that activating mutations 
of WASP are likely to affect the immune system more broadly. We generated mouse models 
to assess the role of activating WASP mutations associated with XLN (XLN-WASP) in  
lymphocytes. XLN-WASP is expressed stably in B and T cells and induces a marked increase 
in polymerized actin. XLN-WASP–expressing B and T cells migrate toward chemokines but 
fail to adhere normally. In marked contrast to WASP-deficient cells, XLN-WASP–expressing 
T cells proliferate normally in response to cell-surface receptor activation. However,  
XLN-WASP–expressing B cells fail to proliferate and secrete lower amounts of antibodies. 
Moreover, XLN-WASP expression in lymphocytes results in modestly increased apoptosis 
associated with increased genomic instability. These data indicate that there are unique 
requirements for the presence and activation status of WASP in B and T cells and that 
WASP-activating mutations interfere with lymphocyte cell survival and genomic stability.
© 2010 Westerberg et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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WASP-L272P and WASP-I296T in vitro, we used assays to 
detect actin-polymerizing activity (Cory et al., 2002; Ancliff 
et al., 2006). Beads coated with WASP-WT, WASP-L272P, 
and WASP-I296T were used to induce actin polymerization 
in cell lysates. In this assay, WASP-WT supported little to no 
actin polymerization (Fig. 1 A, left), supporting the notion 
that WASP resides as an inactive form in the resting state 
(Kim et al., 2000). In contrast, WASP-L272P and WASP-
I296T  induced  a  marked  increase  in  polymerized  actin 
(Fig. 1 A, middle and right). The increased polymerized actin 
induced by WASP-L272P and WASP-I296T was confirmed 
by Western blot analyses (Fig. 1 B). We also confirmed the 
increased actin-polymerizing activity of the XLN-activating 
mutation of WASP (WASP-L272P) by pyrene actin assays 
(unpublished data; Adamovich et al., 2009). To test the ex-
pression and functionality of WASP-L272P and WASP-
I296T,  an  infection  model  was  used.  N-WASP–deficient 
fibroblasts fail to support actin tail formation by the vaccinia 
virus (Fig. 1 C; Snapper et al., 2001). This defect can be res-
cued by expression of WASP-WT, which localizes to the 
pole of the actin tail (Fig. 1 C; Snapper et al., 2001). WASP-
L272P and WASP-I296T supported actin tail formation by 
vaccinia in N-WASP–deficient fibroblasts and localized to 
the pole of actin tails (Fig. 1 C), demonstrating that WASP-
L272P and WASP-I296T are expressed and functional in 
live cells.
eczema and are at increased risk to develop autoimmunity and 
tumors (Notarangelo et al., 2008; Bosticardo et al., 2009). To 
date, at least 150 loss-of-function mutations in the gene encod-
ing WASP have been identified in WAS patients (Thrasher 
and Burns, 2010). Three novel mutations (L270P, S272P, and 
I294T) clustered within the GTPase binding domain of WASP 
were recently identified in patients with a severe congenital 
form of X-linked neutropenia (XLN; Devriendt et al., 2001; 
Ancliff et al., 2006; Beel et al., 2009). The L270P, S272P, and 
I294T mutations destroy the autoinhibited conformation of 
WASP and generate an unfolded protein with enhanced actin-
polymerizing activity (Devriendt et al., 2001; Ancliff et al., 
2006; Beel et al., 2009).
The main features of severe congenital neutropenia are the 
onset of major bacterial infections early in life, paucity of 
mature neutrophils, maturation arrest at the promyelocyte/
myelocyte stage in the bone marrow, and increased risk of de-
veloping leukemia (Dale and Link, 2009). Severe congenital 
neutropenia is caused by loss-of-function mutations in a vari-
ety of proteins including the genes encoding neutrophil elas-
tase, HAX1, and the recently identified glucose-6-phosphatase 
catalytic subunit 3 (Ancliff, 2003; Klein et al., 2007; Boztug   
et al., 2009). The XLN-WASP mutations (L270P, S272P, and 
I294T) add to the genetic complexity of the disease (Devriendt 
et al., 2001; Ancliff et al., 2006; Beel et al., 2009). Although 
deficiency in neutrophil elastase, HAX1, and glucose-6- 
phosphatase catalytic subunit 3 can be explained by increased 
apoptosis of neutrophils and their precursors, it is difficult to 
predict how constitutively active WASP may induce neutro-
penia and how the function of other hematopoietic cells are 
affected. We have recently provided a mechanism for induc-
tion of neutropenia in which forced expression of WASP-
I294T in a monocyte cell line induced increased polymerized 
actin, delayed cell-cycle progression, increased apoptosis, and 
genomic instability with multinucleated and tetraploid cells 
(Moulding et al., 2007).
Because WASP deficiency broadly affects all hematopoi-
etic cells, we hypothesized that XLN mutations in WASP may 
be critical for the function of other hematopoietic cells in ad-
dition to neutrophils. In this report, we aimed to clarify the 
role of WASP-L270P and WASP-I294T in B and T cell func-
tion using novel knockin mouse models. We demonstrate that 
XLN mutations in WASP interferes with normal activation of 
lymphocytes by inducing a marked increase in polymerized 
actin, decreased cell spreading, and increased apoptosis associ-
ated with increased genomic instability.
RESULTS AND DISCUSSION
WASP-L272P and WASP-I296T induce increased actin 
polymerization in vitro, and are stably expressed  
and functional in live cells
We first sought to determine if mouse XLN mutations of 
WASP, WASP-L272P, and WASP-I296T, corresponding to 
the  human  WASP-L270P  and  WASP-I294T  mutations, 
would lead to increased activation of WASP, and if they are 
expressed and functional in live cells. To test the activity of 
Figure 1.  WASP-L272P and WASP-I296T induce increased actin 
polymerization in vitro, and are stably expressed and functional in 
live cells. (A and B) In vitro actin-polymerizing assay. GST-WASP fusion 
proteins were purified with glutathione sepharose beads and incubated 
with cell lysates to induce actin polymerization. Polymerized actin (F-actin) 
was visualized on beads after labeling with phalloidin (A) or by Western 
blotting using anti-actin antibodies (B). Bars, 100 µm. (C) Expression of 
WASP and rescue of vaccinia actin tail formation. Retrovirions expressing 
WASP-WT, WASP-L272P, and WASP-I296T with an N-terminal flag tag were 
used for protein expression in N-WASP–deficient fibroblasts. The cells were 
subsequently infected with vaccinia virus that forms characteristic actin 
tails visualized with phalloidin (green). Localization of WASP proteins was 
determined using anti-flag antibodies (red). Vaccinia fails to form tails in 
untransduced N-WASP–deficient fibroblasts (left). Insets show higher mag-
nification of boxed areas highlighting vaccinia virus actin tails. Bars, 20 µm. 
These experiments represent one of at least three independent experiments.JEM VOL. 207, June 7, 2010  1147
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polymerized actin (Fig. 2 B). We used a complementary gene 
therapy approach (Klein et al., 2003) and showed that an-
other XLN mutation, WASP-L272P, was expressed in T cells 
(Fig. S2 A) and induced markedly elevated levels of polymer-
ized actin (Fig. S2 B). These results demonstrate that WASP-
L272P and WASP-I296T are stably expressed in lymphocytes 
and induce markedly increased polymerized actin.
Normal migratory response but reduced spreading  
of WASP-L272P and WASP-I296T B and T cells
Because WASP family members play a critical role in cytoskel-
etal reorganization and correct trafficking of immune cells, we 
examined receptor-mediated cytoskeletal responses of lym-
phocytes expressing activating mutations of WASP. An in vitro 
chemotaxis assay was used to address whether WASP-I296T 
expression would influence the migration of B and T cells in 
response to the chemokines CCL19 and CXCL12, which are 
critical for homing of mature B and T cells into lymphoid or-
gans. The migration of WASP-I296T B and T cells to CXCL12 
and CCL19, respectively, was indistinguishable from WT cells 
(Fig. 3 A), whereas WASP-deficient B and T cells displayed a 
decreased migratory response, as previously shown (Fig. 3 A; 
Snapper et al., 2005; Westerberg et al., 2005). To model the 
contact area between a T cell and an antigen-presenting cell,   
T cells were incubated on surfaces coated with antibodies to 
CD3 and CD28 that mimic T cell receptor activation. The   
T cell receptor–induced and actin-dependent spreading re-
sponse of both WASP-I296T and WASP-deficient T cells was 
significantly reduced as compared with WT cells (Fig. 3 B, 
top; and Fig. 3 C, left). To assess the effect of WASP-I296T on 
B cell spreading, activated B cells were incubated on surfaces 
coated with antibodies to CD44. A high percentage of WT   
B cells formed large protrusions (Fig. 3 B, bottom left), whereas 
WASP-deficient B cells showed decreased formation of large 
protrusions, as previously shown (Fig. 3 B, bottom middle; and 
Fig. 3 C, right; Westerberg et al., 2001). WASP-I296T B cells 
showed an even more pronounced defect in the formation of 
long protrusions (Fig. 3 B, bottom right; and Fig. 3 C, right). 
Notably, although the WASP-I296T B cells failed to form 
long protrusions, some of the cells formed many short protru-
sions (Fig. 3 B, right), consistent with aberrant cytoskeletal 
regulation of cell shape in these cells. We also examined the 
migratory and spreading response of the additional XLN mu-
tation, WASP-L272P, in B and T cells using the gene therapy 
model. Similar to the findings with WASP-I296T, the migra-
tory response of WASP-L272P B and T cells was similar to 
WT cells (Fig. S2 C). The spreading response of WASP-L272P 
T cells and the formation of long protrusions by WASP-L272P 
B cells were decreased similarly to the response of WASP- 
deficient cells (Fig. S2 D).
Decreased surface receptor–induced proliferative responses 
of WASP-I296T B cells but not T cells
The actin cytoskeleton plays a key role in mitosis and pharma-
cologically induced actin disorganization leads to growth arrest 
(Gachet et al., 2001; Ganem and Pellman, 2007). In mice,   
WASP-I296T and WASP-L272P are expressed in B and T cells 
and induce a marked increase in polymerized actin
To determine the role of activating WASP mutations in hema-
topoietic cells, we assembled a bacterial artificial chromosome 
(BAC) containing the activating WASP-I296T mutation that 
was used to target embryonic stem (ES) cells (Fig. S1 A; Cotta-
de-Almeida et al., 2003). Appropriately targeted ES cells were 
identified by unique restriction enzyme digestion (Fig. S1 B), 
and confirmed by fluorescent in situ hybridization (FISH) using 
a WASP probe (Fig. S1 C) and by direct sequencing of the tar-
geted region (Fig. S1 D). To investigate the function of activated 
WASP mutations in lymphocytes, we used RAG-2–deficient 
blastocyst complementation with WASP-I296T–targeted ES 
cells (Chen et al., 1993). Blastocysts from RAG-2–deficient 
mice implanted into foster mothers generate animals that fail to 
rearrange antigen receptor genes and consequently lack mature 
B and T cells. Injection of gene-targeted ES cells into RAG-2–
deficient blastocysts leads to the generation of somatic chime-
ras in which all mature B and T cells derive from the injected 
ES cells. We found no profound block in development of B 
and T cell lineage cells in the WASP-I296T mice (unpublished 
data). WASP-I296T was expressed at similar levels to WASP-
WT in lymph node and spleen B and T cells (Fig. 2 A). To assess 
the actin-polymerizing activity of WASP-I296T in vivo, the 
quantity of polymerized actin was determined in naive B and 
T cells. Although WASP-WT and WASP-deficient B and 
T cells had a similar quantity of polymerized actin, B and T 
cells expressing WASP-I296T had markedly elevated levels of 
Figure 2.  WASP-I296T and WASP-L272P are expressed in B and  
T cells and induce marked increase in polymerized actin. (A) WASP ex-
pression. Spleen and lymph node T and B cells were stained for WASP using 
an anti-WASP antibody followed by flow cytometric analysis. (B) Polymerized 
actin (F-actin) content. Spleen and lymph node T and B cells were stained 
with phalloidin to detect F-actin and analyzed by flow cytometry. Each panel 
shows one representative histogram (left) and one graph (right) of mean 
values (±SD) of six experiments (n = 6; A) and five experiments (n = 5; B).1148 Active mutations of WASP lead to dysfunctional lymphocytes | Westerberg et al.
(Fig. 4, B and C; Westerberg et al., 2005). WASP-I296T cells 
showed a tendency to decreased class switching as compared 
with WT B cells, although this difference did not reach signifi-
cance (Fig. 4, B and C). We next examined antibody secretion 
and found that WASP-I296T B cells showed a marked reduction 
in secretion of both IgG2b and IgG1 as compared with WT and 
we and others have previously shown that WASP is essential   
for receptor-mediated T cell proliferation, whereas WASP- 
deficient B cells proliferate normally (Snapper et al., 1998; 
Zhang et al., 1999; Cotta-de-Almeida et al., 2007). We sought 
to determine the influence of constitutively active WASP on 
surface receptor–induced proliferation of lymphocytes. Al-
though WASP-deficient T cells showed nearly completely 
abolished proliferative responses, WASP-I296T T cells prolif-
erated similarly to WT T cells (Fig. 4 A, left). In contrast, 
WASP-I296T  B  cells  showed  reduced  proliferation  when 
compared with both WT and WASP-deficient B cells (Fig. 4 A, 
left). We addressed whether the decreased proliferative re-
sponse of WASP-I296T B cells would influence antibody class 
switch  recombination.  WT,  WASP-deficient,  and  WASP-
I296T B cells were cultured with LPS or IL-4 plus anti-CD40 
antibodies to induce switching to IgG2b and IgG1, respec-
tively. As we have previously shown, WASP-deficient B cells 
showed  an  increased  frequency  of  IgG2b-,  and  to  a  lesser   
extent, IgG1-switched B cells as compared with WT B cells 
Figure 3.  Normal migratory response but reduced spreading of 
WASP-L272P and WASP-I296T B and T cells. (A) Migration. Spleen B 
or T cells were allowed to migrate to CXCL12 or CCL19 for 3 h using an in 
vitro chemotaxis chamber. Migrating cells were collected and enumerated 
by flow cytometry with reference beads. The percentage of migrating cells 
is shown as mean values (±SD) of triplicate wells and is representative of 
at least three experiments. *, P < 0.05 compared with WT. (B) Spreading. 
(top) Spreading of T cells was assessed on anti-CD3 plus anti-CD28 
antibody–coated surfaces. Closed white arrows depict the formation of 
large sheet-like lamellipodia of spread T cells. Bars, 25 µm. (bottom) Spreading 
of activated B cells was assessed on anti-CD44 antibody–coated surfaces. 
Closed white arrows depict the formation of long protrusions of spread B 
cells and open white arrows depict spread cells with many short protru-
sions. Bars, 40 µm. (C) Graphs show the mean of relative numbers (±SD) 
of spread T (left) and B cells (right) in triplicates and are representative of 
three experiments. *, P < 0.05 compared with WT.
Figure 4.  WASP-I296T reduces the proliferative response of B 
cells, but not T cells, and leads to modestly increased apoptosis. 
(A) Proliferation. Spleen T (left) and B cells (right) were stimulated for 48 h 
with the indicated stimulus followed by a 16-h pulse with [3H]thymidine 
to determine the proliferative response. Bars are representative mean 
values of cpm ([3H]thymidine) ± SD of triplicate wells from one of at least 
three independent experiments. *, P < 0.05 compared with WT. (B and C) 
Spleen B cells were stimulated with LPS (B) and anti-CD40 plus IL-4 (C) 
for 96 h and assessed for IgG2b (B) and IgG1 (C) class switching by intra-
cellular staining and antibody secretion by ELISA. Each panel shows one 
representative histogram (left) and one graph of mean values (±SD) of 
three different mice (middle). The dashed lines in the WT histograms (left) 
indicate the isotype control. Graphs (right) show secretion of IgG2b (B) 
and IgG1 (C) by ELISA. Each graph represents mean values (±SD) of three 
different mice. B and C represent one out of two similar experiments.  
*, P < 0.05 compared with WT. (D) Apoptosis. Spleen T and B cells were 
stimulated with the indicated stimulus for 72 h. The percentage of apop-
totic cells was assessed after labeling with 7AAD and annexin V and flow 
cytometric analysis. Apoptotic cells were defined as annexin Vhigh7AADlo. 
Each panel shows one representative histogram (left) and one graph of 
mean values (±SD) of three or more experiments (right). In each case, 
although there were statistically significant differences (P < 0.05) in 
apoptosis between WASP-I296T cells when compared with WASP-WT in 
most individual experiments, because of the variability, statistical  
significance was not met when compiling all experiments.JEM VOL. 207, June 7, 2010  1149
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lecular model for WASP activation in which the open, active 
conformation of WASP leads to increased polymerized actin. 
Although regulated polarization of actin is a key feature of 
T and B cell receptor activation (Batista and Harwood, 2009; 
Dustin, 2009), little is known about how an increased pool of 
polymerized actin would influence the function of lympho-
cytes. We demonstrate that increased polymerized actin is as-
sociated with a unique dysfunction of lymphocytes, including 
decreased cell spreading and increased apoptosis. Two recent 
papers show that deficiency in coronin1A, a negative regulator 
of actin dynamics, leads to increased polymerized actin in thymo-
cytes and T cells associated with increased apoptosis (Föger et al., 
2006; Shiow et al., 2008). Although coronin1A-deficient thy-
mocytes and T cells have a decreased capacity to migrate to 
chemokines in vitro and fail to egress normally from the thymus 
(Föger et al., 2006; Shiow et al., 2008), our results show that 
WASP-I296T B and T cells migrate normally to chemokines. 
This indicates that in addition to increased polymerized actin 
in WASP-I296T B and T cells (which is also appreciated in 
cononin1A-deficient cells), constitutive activation of WASP 
WASP-deficient cells (Fig. 4, B and C). These results suggest 
that B and T cells have different requirements for WASP activ-
ity during cell proliferation and that T cells are clearly sensitive 
to WASP deficiency, whereas B cells are sensitive to constitu-
tive activation of WASP. Moreover, B cells expressing con-
stitutively active WASP have decreased secretion of antibodies.
WASP-I296T induces a modestly increased apoptosis  
of B and T cells
Bone marrow cells from one WASP-I294T patient demon-
strated increased polymerized actin and a greater percentage of 
apoptotic cells as compared with cells from a healthy individual 
(Ancliff et al., 2006). Moreover, pharmacologically induced 
actin polymerization leads to increased apoptosis of monocyte 
cells (Moulding et al., 2007), suggesting that an increased load 
of polymerized actin renders cells prone to undergoing apop-
tosis. We examined whether increased polymerized actin in 
WASP-I296T lymphocytes was associated with increased apop-
tosis. Compared with WT and WASP-deficient B and T cells, 
expression of WASP-I296T led to a modest increase in receptor-
induced apoptosis that was greater in B cells than in T cells 
(Fig. 4 D and Fig. S3).
Increased genomic instability in WASP-I296T B and T cells
Our data indicate that B and T cells expressing WASP-I296T 
have increased polymerized actin and are prone to apoptosis. 
These processes are associated with increased genomic instability 
(Ganem and Pellman, 2007; Moulding et al., 2007). To directly 
determine a potential role of WASP-I296T in the mainte-
nance of genomic stability, we used a telomere-FISH assay that 
combines DAPI staining of chromosomes with a telomere-
specific peptide nucleic acid probe to assay metaphase chromo-
somes for chromosomal abnormalities (Zha et al., 2007). WT and 
WASP-deficient B and WT T cells showed few if any chromo-
somal aberrations (Fig. 5, top left; and Table I). It was not possible 
to assess genomic instability in WASP-deficient T cells because 
they fail to proliferate in response to receptor activation (Fig. 4 A). 
In contrast, WASP-I296T B and T cells showed increased ge-
nomic instability, including chromosome breaks, doublet and 
fused chromosomes, and tetraploidy (Fig. 5 and Table I). Overall, 
these findings indicate that WASP activation and its associated 
cytoskeletal changes alter genomic stability in lymphocytes.
We have used novel mouse models to demonstrate that 
constitutively active WASP induces increased polymerized   
actin in B and T cells, and this is associated with decreased spread-
ing, greater apoptosis, and increased genomic instability. Three 
XLN mutations (L270P, S272P, and I294T) in patients are pre-
dicted to destabilize the autoinhibited conformation of WASP 
and render WASP constitutively active (Devriendt et al., 
2001; Ancliff et al., 2006; Beel et al., 2009). Biochemical analy-
sis revealed that WASP-L270P is more rapidly degraded by 
proteases in vitro than WT WASP (Devriendt et al., 2001). It 
was previously shown that WASP is expressed in peripheral 
blood cells from XLN patients (Devriendt et al., 2001). Our 
results now show that mouse WASP-L272P and WASP-I296T 
are expressed stably in lymphocytes. Our data support the mo-
Figure 5.  Increased genomic instability in WASP-I296T B and T 
cells. (A) Examples of cytogenetic abnormalities observed in WASP-I296T  
B and T cells. DAPI-stained chromosomes are blue, with the centromeres 
being visualized as more intense blue ovals. Red dots come from telomere 
signals. The top left micrograph depicts a normal metaphase with 40 chro-
mosomes, each consisting of two sister chromatids and four telomeres. The 
schematic drawing represents one chromsome with two sister chromatids. 
The orange arrow denotes telomeres at the long arms and the green arrow 
denotes telomeres on the short arms of the chromatids. Insets show higher 
magnification of boxed areas to highlight normal and altered chromosomes. 
The other micrographs depict representative chromosomal abnormalities 
including chromosomal breaks (top middle micrograph), doublet chromo-
somes with breaks (top right micrograph), a fused chromosome (bottom left 
micrograph), a metaphase with >40 chromosomes (bottom middle micro-
graph), and a nucleus with >40 chromosomes, i.e., >160 telomeres (bottom 
right micrograph). Closed white arrowheads in the magnified images be-
neath the micrographs denote chromosomal breaks. The open white arrow-
head denotes two fused chromosomes with a large centromere. Bars, 2 µm.1150 Active mutations of WASP lead to dysfunctional lymphocytes | Westerberg et al.
have previously shown that one WASP-I294T patient had in-
trinsic defects of myelopoiesis with increased apoptosis in the 
bone marrow and variable acquired cytogenetic abnormalities 
(Ancliff et al., 2006). Our results now show that increased 
polymerized actin in B and T cells expressing WASP-I296T is 
associated with greater apoptosis and increased genomic insta-
bility. It remains to be determined if genomic instability in 
WASP-I296T hematopoietic cells leads to tumor transforma-
tion. This may be a critical issue to consider for the manage-
ment of XLN patients.
A considerable percentage of severe congenital neutrope-
nia patients have unknown etiology. We predict that some of 
these patients harbor constitutively active mutations in WASP. 
In support of this notion, we recently identified the WASP-
I294T mutation in a large family with severe congenital neu-
tropenia (Beel et al., 2009). Our data show that mouse XLN 
mutations of WASP induce a marked increase in polymerized 
actin in naive B and T cells. Together with our previous results 
(Westerberg et al., 2005; Ancliff et al., 2006; Moulding et al., 2007), 
we have determined that increased polymerized actin in hema-
topoietic cells may be a unique feature of WASP-associated 
severe congenital neutropenia and can potentially provide a 
useful screening method to identify new XLN patients.
MATERIALS AND METHODS
Animals. Mice were housed at Children’s Hospital Boston and at Massachu-
setts General Hospital under specific pathogen–free conditions. Animal exper-
iments were performed after approval and in accordance with guidelines from 
the Subcommittee on Research Animal Care of Children’s Hospital Boston 
and Massachusetts General Hospital.
Generation of DNA constructs and targeted ES cells. The amino acid 
sequence in the GTPase binding domain spanning the human XLN mutations 
may alter unique actin-dependent and/or -independent func-
tions. Collectively, these results add to the complexity of actin 
cytoskeletal dynamics in lymphocytes in which an increased 
load of polymerized actin may be as devastating as altered   
polarization of polymerized actin.
Our results define different requirements for WASP activ-
ity in B and T cells with regard to cell proliferation. A hallmark 
of WASP deficiency in mice is that WASP-deficient T cells fail 
to respond to T cell receptor activation (Snapper et al., 1998; 
Zhang et al., 1999; Cotta-de-Almeida et al., 2007). We now 
show that WASP-I296T–expressing T cells proliferate nor-
mally to surface receptor stimulation. In marked contrast, 
WASP-deficient B cells have normal surface receptor–induced 
proliferation, whereas WASP-I296T–expressing B cells showed 
a markedly decreased proliferative response. This demonstrates 
that B and T cells have different requirements for WASP activ-
ity, and that T cells are sensitive to WASP deficiency, whereas 
B cells are more sensitive to constitutively active WASP. We 
have previously shown that N-WASP rescues many critical 
functions of WASP in WASP-deficient thymocytes (Cotta-de-
Almeida et al., 2007). N-WASP may not be able to rescue the 
function of constitutively active WASP if its activity is domi-
nant. In this regard, forced expression of WASP-I294T in a 
monocyte cell line that expresses WT WASP induces increased 
polymerized actin, decreased cell-cycle progression, and increased 
apoptosis, strongly suggesting that constitutively active WASP 
is dominant over WT WASP activity (Moulding et al., 2007).
Actin is critical during cell division to correctly segregate 
chromosomes and for cytokinesis by regulating the contractile 
ring of actin and myosin that cleaves the cell into two daughter 
cells (Gachet et al., 2001; Ganem and Pellman, 2007). We 
Table I.  Genomic instability in WASP-I296T B and T cells
Metaphases Chromosome breaks >40 chromosomes per 
metaphase
>40 chromosomes per 
nucleus
Other
B cells
WT WASP 51 0 0 0 0
131 0 0 0 0
79 0 0 0 0
WASP KO 81 1 0 0 0
71 0 0 0 0
54 0 0 2 0
WASP-I296T 160 3 16 1 1 fused chromosome
73 2 0 4 2 doublet chromosomes
56 1 0 0 0
T cells
WT WASP 50 0 0 0 0
38 0 0 0 0
72 0 0 0 1 doublet chromosome
WASP-I296T 39 0 0 0 0
206 17 0 0 1 doublet chromosome
64 3 1 0 1 doublet chromosome
Quantification of chromosomal aberrations in B and T cells. Each row represents an analysis of cells from one mouse. It was not possible to assess genomic instability in 
WASP-deficient T cells because they fail to proliferate in response to receptor activation.JEM VOL. 207, June 7, 2010  1151
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poly–l-lysine–precoated slides, coated with anti-CD3 and anti-CD28 anti-
bodies (eBioscience) for 10 min. B cells were cultured for 48 h in LPS (Sigma-
Aldrich) and IL-4 (PeproTech), and incubated on anti-CD44 antibody–coated 
slides, precoated with poly–l-lysine, for 8 h. Cells were fixed and stained with 
Alexa Fluor 488–phalloidin. Spread T cells were defined as having a flattened 
appearance and formation of actin-rich broad lamellipodia as compared with 
nonspread round cells. Spread B cells were defined as having at least one pro-
trusion longer than one cell diameter in length as compared with nonspread 
cells. For proliferation, detection of immunoglobulins, and apoptosis, T cells were 
purified using Dynabeads (Invitrogen) and stimulated with platebound anti-
CD3 with or without soluble anti-CD28 stimulating antibodies (eBioscience). 
B cells were purified with the CellSep B cell enrichment kit (STEMCELL 
Technologies Inc.) and cultured with LPS or anti-CD40 antibodies (eBiosci-
ence) plus IL-4. The proliferative response was assessed as previously described 
using [3H]thymidine incorporation (Snapper et al., 1998; Cotta-de-Almeida 
et al., 2007). Antibody class switching and secretion were assessed as previ-
ously described using intracellular staining and ELISA for IgG2b and IgG1 
(Westerberg et al., 2005, 2008). The frequency of apoptosis was determined as 
previously described (Cotta-de-Almeida et al., 2007; Westerberg et al., 2008) 
and apoptotic cells were defined as annexin Vhigh7AADlo by flow cytometry.
Telomere-FISH. To assess genomic instability, purified B cells were cultured 
with LPS plus IL-4 and T cells with platebound anti-CD3 and soluble anti-
CD28 antibodies for 72 h and prepared for telomere-FISH analysis as previously 
described (Zha et al., 2007). In brief, cells were treated with the microtubule 
inhibitor colcemid (Invitrogen) for 5 h to arrest proliferating cells in metaphase. 
Cells were treated with hypotonic 0.075 M KCl, fixed in MeOH:glacial acetic 
acid, and dropped on glass slides to generate metaphase spread chromosomes. 
Telomeres were stained with a Cy3-labeled (CCCTAA)3 peptide nucleic acid 
probe (Panagene), and DNA was counterstained with DAPI.
Fluorescence  microscopy.  All  slides  for  fluorescent  microscopy  were 
viewed with a research system microscope (Provis AX70; Olympus) using a 
UplanFl lens at 100× and Mowiol medium (EMD). Images were acquired   
using a U-PHOTO Universal Photo System camera (U-CMAD-2; Olympus) 
and were processed with MagnaFire 2.1c (Optronics) and Photoshop CS 
(version 8.0; Adobe Systems).
Gene therapy model. The gene therapy model was previously described 
(Klein et al., 2003). In brief, vesicular stomatitis virus-g–pseudotyped retro-
viruses  were  generated  by  transient  transfection  of  CMMPiresGFP-based 
WASP-WT, WASP-L272P, and empty vector (WASP KO) plasmids into the 
packaging cell line 293GPG. The supernatant was concentrated and used to 
infect WASP-deficient Sca-1+lin progenitor cells at a multiplicity of infection 
of 10 in the presence of 8 µg/ml polybrene. GFP+ progenitor cells were   
injected retroorbitally into lethally irradiated WT recipient mice. Mice were 
used at week 12 after transplant.
Online supplemental material. Fig. S1 shows the targeting strategy and 
screening to generate WASP-I296T knockin ES cells. Fig. S2 shows func-
tional analysis of lymphocytes from the XLN-WASP-L272P gene therapy 
model. Fig. S3 shows detection of apoptotic B and T cells using staining with 
anti-active caspase-3 antibodies. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20091245/DC1.
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of WASP is identical between humans and mice. Based on this sequence iden-
tity, we determined that the mouse mutations WASP-L272P and WASP-
I296T would correspond to the human XLN mutations WASP-L270P and 
WASP-I294T, respectively. To generate the glutathione S-transferase (GST)–
WASP-WT, WASP-L272P, and WASP-I296T fusion proteins, the WASP 
cDNA was subcloned into the pEBG vector (a gift from V. Yajnik, Harvard 
Medical School, Boston, MA), and the L272P (TTG to CCG) and I296T (ATT 
to ACT) mutations were inserted by site-directed mutagenesis and confirmed 
by sequencing. The generation of the CMMP-WASP-iresGFP retroviral con-
struct was described previously (Klein et al., 2003), and is now modified by in-
sertion of the L272P and I296T mutations as for the GST constructs. In each 
retrovirus, a flag tag was inserted 5 of the ATG start codon of the WASP-WT, 
WASP-L272P, and WASP-I296T cDNAs to detect WASP protein by immu-
noflourescence. To assemble the WASP-I296T targeting construct, we used 
BAC recombineering with some modifications to the previously described 
method (Cotta-de-Almeida et al., 2003). In brief, 1 kb of genomic WASP span-
ning exon 9 was cloned into the pSBS171 vector containing an aminoglycoside 
phosphotransferase (aph) gene cassette flanked by loxP sites and the WASP-
I296T mutation was inserted. A 3-kb PCR product encompassing WASP-
I296T-loxP-aph-loxP was transformed into bacteria carrying a BAC containing 
the WASP gene (BACPAC Resources Center at the Children’s Hospital Oak-
land Research Institute). Insertion of WASP-I296T-loxP-aph-loxP into the 
WASP-containing BAC was performed by homologous recombination medi-
ated by the Red recombination system from bacteriophage . The WASP-
I296T BAC was linearized with SgrA1 and used for transfection into J1 ES cells 
(Yang and Seed, 2003). Two homologous targeted ES cell clones were identi-
fied by specific endonuclease digestion using Dde1, FISH, and sequencing   
(Fig. S1, A–D). After deletion of the loxP-aph-loxP cassette by transient expres-
sion of the Cre recombinase, two subclones of WASP-I296T ES cells were in-
jected into RAG-2–deficient blastocysts to generate somatic chimeras in which 
all lymphocytes derive from the WASP-I296T–targeted ES cells (Chen et al., 
1993). WT ES cells were injected for RAG-2–deficient blastocyst complemen-
tation and used for analysis of WT lymphocytes.
F-actin  polymerization  assay  and  vaccinia  infection.  To  determine   
actin-polymerizing activity, a bead assay was used (Cory et al., 2002). In brief, 
GST-WASP fusion proteins were purified from lysates of COS-7 epithelial 
cells with glutathione sepharose 4B beads (GE Healthcare). To induce actin 
polymerization, WASP-coated beads were incubated with U937 cell lysates   
in the presence of 5 mM MgCl2. Beads were labeled with Alexa Fluor 488–
phalloidin (Invitrogen) to visualize polymerized F-actin by fluorescence mi-
croscopy or were boiled in SDS-PAGE loading buffer and analyzed by Western 
blotting using a monoclonal anti-GST antibody (Santa Cruz Biotechnology, 
Inc.) to detect GST-WASP fusion proteins and a monoclonal mouse anti-actin 
antibody (Sigma-Aldrich) to detect actin. For vaccinia rescue assays, N-WASP–
deficient fibroblasts were transduced with concentrated retroviruses expressing 
WASP-WT,  WASP-L272P,  or  WASP-I296T  and  infected  with  vaccinia 
(Snapper et al., 2001). Polymerized actin in vaccinia tails were labeled with   
Alexa Fluor 488–phalloidin and flag-WASP detected using an anti-flag anti-
body (Santa Cruz Biotechnology, Inc.) followed by Cy3-conjugated rat anti–
mouse secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.).
Flow cytometry. Single-cell suspensions were labeled with fluorescently con-
jugated anti–mouse antibodies including B220, TCR, CD4, and CD8 (eBio-
science). For intracellular staining, cells were labeled with purified polyclonal 
rabbit  anti-WASP  antibody  (a  gift  from  L.  Notarangelo,  Harvard  Medical 
School, Boston, MA) followed by a donkey anti–rabbit secondary antibody 
(Jackson ImmunoResearch Laboratories, Inc.) with Alexa Fluor 488–phalloidin 
to detect polymerized actin or with anti-active caspase-3 (Promega). Data were 
acquired on a FACSCalibur (BD) and analyzed using FlowJo (Tree Star, Inc.).
In vitro chemotaxis, spreading, proliferation, immunoglobulin de-
tection, and apoptosis. In vitro migration of B and T cells and spreading of 
B and T cells was assessed as previously described (Westerberg et al., 2001, 
2008; Cotta-de-Almeida et al., 2007). For spreading, T cells were incubated on 1152 Active mutations of WASP lead to dysfunctional lymphocytes | Westerberg et al.
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